ZOCCHI, ELENA
 Distribuzione geografica
Continente #
EU - Europa 23.783
AS - Asia 26
SA - Sud America 4
AF - Africa 1
NA - Nord America 1
Totale 23.815
Nazione #
IT - Italia 23.783
CN - Cina 19
BR - Brasile 4
SG - Singapore 3
VN - Vietnam 2
HK - Hong Kong 1
KG - Kirghizistan 1
MA - Marocco 1
US - Stati Uniti d'America 1
Totale 23.815
Città #
Genova 14.600
Genoa 5.819
Rapallo 1.917
Vado Ligure 1.398
Bordighera 48
Beijing 7
Singapore 2
Anápolis 1
Ashburn 1
Da Nang 1
Feira de Santana 1
Hefei 1
Ho Chi Minh City 1
Hong Kong 1
Milan 1
Praia Grande 1
Santa Vitória 1
Totale 23.801
Nome #
Abscisic acid enhances glucose disposal and induces brown fat activity in adipocytes in vitro and in vivo 224
Abscisic acid is an endogenous stimulator of insulin release from human pancreatic islets with cyclic ADP-ribose as second messenger. 214
Impaired increase of plasma abscisic acid in response to oral glucose load in type 2 diabetes and in gestational diabetes 209
G(s) protein dysfunction in allergen-challenged human isolated passively sensitized bronchi. 197
Abscisic acid enhances cold tolerance in honeybee larvae 193
Binding of abscisic acid to human LANCL2 187
Abscisic acid ameliorates the systemic sclerosis fibroblast phenotype in vitro. 185
G-protein coupling and nuclear translocation of the human abscisic acid receptor LANCL2 185
Identification of a high affinity binding site for abscisic acid on human Lanthionine synthetase component C-like protein 2 184
Abscisic Acid Stimulates Glucagon-Like Peptide-1 Secretion from L-Cells and Its Oral Administration Increases Plasma Glucagon-Like Peptide-1 Levels in Rats 182
Abscisic acid is an endogenous cytokine in human granulocytes with cyclic ADP-ribose as second messenger. 180
Abscisic acid enhances glucose disposal and induces brown fat activity in adipocytes in vitro and in vivo 177
Abscisic acid released by human monocytes activates monocytes and vascular smooth muscle cell responses involved in atherogenesis 173
Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling. 170
Abscisic acid and cyclic ADP-ribose are first and second messanger in inflammatory cells, hematopoietic progenitors and pancreatic beta-cells 168
Abscisic Acid transport in human erythrocytes. 168
ABA- and cADPR-mediated effects on respiration and filtration downstream of the temperature-signaling cascade in sponges 166
Synthesis, structural characterization and effect on human granulocyte intracellular cAMP levels of abscisic acid analogs 166
The plant hormone abscisic acid stimulates the proliferation of human hemopoietic progenitors through the second messenger cyclic ADP-ribose 164
T cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia 163
A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes 162
ABA says NO to UV-B: a universal response? 161
Autocrine abscisic acid mediates the UV-B-induced inflammatory response in human granulocytes and keratinocytes 160
Cyclic ADP-ribose generation by CD38 improves human hemopoietic stem cell engraftment into NOD/SCID mice 160
Chronic intake of micrograms of abscisic acid improves glycemia and lipidemia in a human study and in high-glucose fed mice 160
A self restricted CD38-connexin 43 cross-talk affects NAD+ and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts 159
Microgram amounts of abscisic acid in fruit extracts improve glucose tolerance and reduce insulinemia in rats and in humans 159
Abscisic acid influx into human nucleated cells occurs through the anion exchanger AE2 159
Concentrative influx of functionally active cyclic ADP-ribose in dimethylsulfoxide-differentiated HL-60 cells 159
Adenylic dinucleotides produced by CD38 are negative endogenous modulators of platelet aggregation 158
ADP-ribosyl cyclase and abscisic acid are involved in the seasonal growth and in post-traumatic tissue regeneration of Mediterranean sponges. 157
Abscisic acid activates the murine microglial cell line N9 through the second messenger cyclic ADP-ribose 155
A monoclonal antibody to platelet glycoproteins IIb and IIIa complex: its use in purifying human megakaryocytes from sternal bone marrow aspirates for immunofluorescence studies of Ia-like antigens. 155
Abscisic acid and cyclic ADP-ribose are first and second messengers in inflammatory cells and hemopoietic progenitors 153
Modified in vitro conditions for cord blood-derived long-term culture initiating cells. 152
Subcellular and intercellular traffic of NAD+, NAD+ precursors and NAD+-derived signalmetabolites and second messengers: Old and new topological paradoxes 152
Abscisic acid signaling through cyclic ADP-ribose in hydroid regeneration 150
Selection and characterization of single stranded DNA aptamers for the hormone abscisic Acid 150
Concentrative uptake of cyclic ADP-ribose generated by BST-1+ stroma stimulates proliferation of human hematopoietic progenitors 150
Dimeric and tetrameric forms of catalytically active transmembrane CD38 in transfected HeLa cells 147
LANCL2 is the abscisic acid receptor in human granulocytes and in rat insulinoma cells. 146
Impaired increase of plasma abscisic acid in response to oral glucose load in type 2 diabetes and in gestational diabetes 146
Abscisic Acid: A Novel Nutraceutical for Glycemic Control 146
Functional characterization of a synthetic abscisic acid analog with anti-inflammatory activity on human granulocytes and monocytes 145
Mitochondrial dysfunction induced by a cytotoxic adenine dinucleotide produced by ADP-ribosyl cyclases from cADPR. 145
Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes 142
Paracrine roles of NAD+ and Cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts 140
Insulin-independent stimulation of skeletal muscle glucose uptake by low-dose abscisic acid via AMPK activation 140
Autocrine and paracrine calcium signalling by the CD38/NAD+/cyclic ADP-ribose system 139
Adenosine diphosphate ribulose in human erythrocytes: a new metabolite with membrane binding properties 139
Synthetic analogues of abscisic acid with anti-inflammatory and insulin release stimulation effects on human cells 139
Abscisic acid and cyclic ADP-ribose increase intracellular Ca2+ and stimulate proliferation of human mesenchymal stem cells. 139
Abscisic acid transport in human erythrocytes 139
The Plant Hormone Abscisic Acid is a Pro-Survival Factor in Human and Murine Megakaryocytes 138
Autocrine abscisic acid plays a key role in quartz-induced macrophage activation 137
Equilibrative and concentrative nucleoside transporters mediate the influx of Cyclic ADP-ribose into 3T3 murine fibroblasts. 137
Fluridone as a new anti-inflammatory drug 137
Abscisic acid produced by human monocytes stimulates monocyte and vascular smooth muscle cell responses involved in the development of the atherosclerotic lesion 137
ADP-ribosyl cyclases generate two unusual adenine homodinucleotides with cytotoxic activity on mammalian cells. 137
Enhanced antitumor activity of adriamycin by encapsulation in mouse erythrocytes targeted to liver and lungs. 136
Simple synthesis of P1P2-Diadenosine 5'-pyrophosphate 136
Abscisic Acid: A Conserved Hormone in Plants and Humans and a Promising Aid to Combat Prediabetes and the Metabolic Syndrome. 136
Abscisic acid is an endogenous stimulator of insulin release from human release from human pancreatic islets with cyclic ADP-ribose as second messenger. 134
LANCL2 is necessary for Abscisic acid binding and signaling in human granulocytes and in rat insulinoma cells 134
LANCL2 is the abscisic acid receptor in in human granulocytes and in rat insulinoma cells 133
Abscisic acid produced by human monocyte and vascular smooth muscle cell responses involved in the development of the atherosclerotic lesion. 133
Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model 132
Abscisic acid enhances adipocyte diffentiation and glucose uptake in murine 3T3-L1 and in human ATMSC 132
Toward a medicine-oriented use of the human hormone/nutritional supplement Abscisic Acid 132
NAD+ Levels Control Ca2+ Store Replenishment and Mitogen-induced Increase of Cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 Channel Gating in Human T Lymphocytes. 132
Abscisic acid stimulates the release of insulin and of GLP-1 in the rat perfused pancreas and intestine 130
Favism: impairment of proteolytic systems in red blood cells. 129
The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts 129
NUTRIENT FACTORS PRESENT IN MEDIUM CONDITIONED BY A HUMAN CLONED MYELOMONOCYTIC CELL-LINE GROWTH AT LIMITING DILUTION 129
Cyclic ADP-ribose is a second messenger in the lipopolysaccharide-stimulated activation of murine N9 microglial cell line 129
The association of human mesenchymal stem cells with BMP-7 improves bone regeneration of critical-size segmental bone defects in athymic rats. 128
Mitochondrial dysfunction induced by a cytotoxic adenine dinucleotide produced by ADP-ribosyl cyclases from cADPR 127
Ectocellular CD38-catalyzed synthesis and intracellular Ca(2+)-mobilizing activity of cyclic ADP-ribose. 127
P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy 127
The plant hormone abscisic acid stimulates the proliferation of human hemopoietic progenitors through the second messenger cyclic ADP-ribose. 126
Expression of CD38 increases intracellular calcium concentration and reduces doubling time in HeLa and 3T3 cells. 124
Novel adenylic dinucleotides with anti-tumor activity and method of preparing thereof. 124
P2X7 antagonists improve “in vitro” myelination in organotypic dorsal root ganglia (DRG) cultures from a rat model of CMT1A neuropathy 124
Abscisic acid: a new human adipose tissue-derived hormone? 123
Cyclic ADP-ribose-mediated stimulation of proliferation and immunomodulatory properties of human mesenchymal stem cells by the phytohormone abscisic acid 123
Use of glutaraldehyde treated autologous human erythrocytes for hepatic targeting of doxorubicin. 122
Abscisic acid is an endogenous pro-inflammatory cytokine in human granulocytes with cyclic ADP-ribose as second messenger 122
Cyclic ADP-ribose-mediated expansion and stimulation of human mesenchymal stem cells by the plant hormone abscisic acid 122
NAADP+ synthesis from cADPRP and nicotinic acid by ADP-ribosyl cyclases 121
Abscisic acid and cyclic ADP-ribose increase intracellular Ca++ and stimulate proliferation of human mesenchymal stem cells 121
Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes 121
The CD38/cyclic ADP-ribose system: a topological paradox. 121
Improved metabolic properties of hexokinase-overloaded human erythrocytes 119
Multiple small molecular weight guanine nucleotide-binding proteins in human erythrocyte membranes 119
Production and hydrolysis of cyclic ADP-ribose at the outer surface of human erythrocytes 119
Encapsulation of adriamycin in human erythrocytes 119
Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes. 119
Extracellular cyclic ADP-ribose increases intracellular free calcium concentration and stimulates proliferation of human hemopoietic progenitors. 118
NAADP+ is an agonist of the human P2Y11 purinergic receptor 118
Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes 118
Totale 14.609
Categoria #
all - tutte 73.569
article - articoli 57.850
book - libri 0
conference - conferenze 12.182
curatela - curatele 0
other - altro 0
patent - brevetti 2.668
selected - selezionate 0
volume - volumi 869
Totale 147.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021921 0 0 0 91 92 114 82 94 127 127 98 96
2021/20222.378 70 180 202 272 82 129 183 541 95 239 66 319
2022/20232.318 218 158 28 237 427 384 5 169 385 5 268 34
2023/20241.419 58 170 38 152 119 345 97 53 81 30 106 170
2024/20253.662 177 260 135 277 434 275 329 680 117 132 377 469
2025/20261.843 860 187 390 406 0 0 0 0 0 0 0 0
Totale 24.063